Effects of flurbiprofen on the functional regulation of serotonin transporter and its misfolded mutant
Effects of flurbiprofen on the functional regulation of serotonin transporter and its misfolded mutant
复制标题
氟比洛芬对血清素转运蛋白及其错误折叠突变体功能调节的影响
DOI:
10.1016/j.jphs.2021.11.006
复制
发表时间:
2022
影响因子:
3.5
通讯作者:
Sakai Norio
中科院分区:
文献类型:
--
作者:
Hirakawa Haruki;Taguchi Kei;Murakawa Seiya;Asano Masaya;Noguchi Soma;Kikkawa Satoshi;Harada Kana;Adachi Naoko;Ueyama Takehiko;Hide Izumi;Tanaka Shigeru;Sakai Norio
Flurbiprofen, a nonsteroidal anti-inflammatory drug, reportedly exhibits chemical chaperone activity. Herein, we investigated the role of flurbiprofen in regulating serotonin transporter (SERT) function via membrane trafficking. We used COS-7 cells transiently expressing wild-type (WT) SERT or a C-terminus-deleted mutant of SERT (SERTΔCT), a misfolded protein. Flurbiprofen treatment reduced the expression of immaturely glycosylated SERT and enhanced the expression of maturely glycosylated SERT. In addition, we observed increased serotonin uptake in SERT-expressing cells. These results suggest that flurbiprofen modulates SERT function by promoting membrane trafficking. In SERTΔCT-expressing cells, flurbiprofen reduced the protein expression and uptake activity of SERTΔCT. Furthermore, flurbiprofen inhibited the formation of SERTΔCT aggregates. Studies using flurbiprofen enantiomers suggested that these effects of flurbiprofen on SERT were not mediated via cyclooxygenase inhibition. The levels of GRP78/BiP, an endoplasmic reticulum (ER) stress marker, were assessed to elucidate whether flurbiprofen can ameliorate SERTΔCT-induced ER stress. Interestingly, flurbiprofen induced GRP78/BiP expression only under ER stress conditions and not under steady-state conditions. In HRD1 E3 ubiquitin ligase knockdown cells, flurbiprofen affected the ER-associated degradation system. Collectively, the findings suggest that flurbiprofen may function as an inducer of molecular chaperones, in addition to functioning as a chemical chaperone.